NEUROCRINE ENTERS INTO $108 MILLION SALE/LEASEBACK AGREEMENT

SAN DIEGO — Neurocrine Biosciences Inc. has entered into a sale and leaseback agreement with Veralliance Properties for its real estate assets in San Diego. The total consideration to be received by Neurocrine for the properties is $108 million. Concurrently with the closing of the sale, Neurocrine will leaseback its corporate headquarters under a 10-year lease term.